Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined kidney transplantation and donor hematopoietic stem cell infusion to induce transplant tolerance
MOH_2018-02-18_002196Phase 2Recruiting
- Sponsor
- פרופ' איתן מור
- Start
- Dec 2017
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of antithymocyte globulin rabbit, tacrolimus and mycophenolate mofetil in kidney failure, sponsored by פרופ' איתן מור. Started Dec 2017; status: recruiting.
02
Drugs
antithymocyte globulin rabbittacrolimusmycophenolate mofetil
03
Conditions
kidney failure
Beyond the preview
Go deeper on MOH_2018-02-18_002196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-02-18_002196.